New discovery to kill liver cancer cells

Share This Post

Scientists at the University of Delaware and the University of Illinois at Chicago have discovered a new way to kill liver cancer cells and inhibit tumor growth. First, silence a key cellular enzyme, then add a potent drug. This research can accelerate the development of new treatments for liver cancer that are currently difficult to cure. Surgery is usually not an option for liver cancer, and the available drugs have limited efficacy. According to the National Institutes of Health, more than 82% of liver cancer patients will die within five years. The researchers cultivated liver cancer cells and manipulated the expression of an enzyme called hexokinase-2. Then, the cells were treated with metformin, a diabetes drug that reduces glucose production in the liver. Then, examine how cancer cells respond to the loss of hexokinase-2, an enzyme that helps cells metabolize food-derived glucose. Mass spectrometry was used to analyze cancer cells and then determine the metabolic flux of cells with and without hexokinase-2. They suspected that cells losing hexokinase-2 would starve to death, but surprisingly, targeting hexokinase-2 had only a minor effect on stopping cancer cell growth. Another weapon, metformin, can help stop cancer cells from growing. We show that targeting hexokinase-2 can indeed be a successful strategy for cancer treatment, and that it requires the use of metformin as a second-generation compensation mechanism.Finally, a team from the University of Illinois at Chicago tested the effect of removing the combination of hexokinase-2 and the liver cancer drug sorafenib on liver cancer tumors in mice. This combination was better than the treatment alone.

Website |  + posts

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
CAR T-Cell therapy

Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment

CAR T cell therapy has transformed cancer treatment, especially in hematological malignancies. Treatment of solid tumors remains challenging due to their immunosuppressive tumor microenvironment. Combination with chemotherapy, immune checkpoint inhibitors, oncolytic viruses, and improved genetic engineering holds promise. Multimodal approaches enhance immune cell infiltration and persistence, raising efficacy. Evolving personalized methods will be instrumental in overcoming solid tumor resistance and improving patient outcomes.

How to prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies
CAR T-Cell therapy

How to prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies?

CAR T-cell therapy revolutionized cancer therapy, offering incredible success in the management of B-cell malignancies, but it is associated with severe infection risks secondary to immunosuppression. Preventive measures are pre-infusion screening, vaccination, and antimicrobial prophylaxis. Post-infusion, close surveillance for infection and cytokine release syndrome management are key. Long-term care includes the treatment of hypogammaglobulinemia, revaccination, and patient education. The approach ensures improved outcomes and reduces infection-related complications in patients receiving CD19-targeted CAR T-cell therapy.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

CancerFax is the most trusted online platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies.

Send your medical reports and get a free analysis.

🌟 Join us in the fight against cancer! 🌟

Привет,

CancerFax — это самая надежная онлайн-платформа, призванная предоставить людям, столкнувшимся с раком на поздних стадиях, доступ к революционным клеточным методам лечения.

Отправьте свои медицинские заключения и получите бесплатный анализ.

🌟 Присоединяйтесь к нам в борьбе с раком! 🌟